Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population

Clinical Genetics

Volumn 76, Issue 6, 2009, Pages 511-523

  Levesque S ^a,b   Dombrowski, C ^a,b   Morel, M L ^a,b   Rehel, R ^a,b   Cote J S ^a,b   Bussieres J ^a,b   Morgan, K ^c   Rousseau, F ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Fragile X syndrome; Incidence; Instability; Population; Screening; Transmission

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ADULT; ARTICLE; DNA PURIFICATION; FEMALE; FRAGILE X SYNDROME; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENOMIC INSTABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; MOTHER CHILD RELATION; NEWBORN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEX DIFFERENCE; SOUTHERN BLOTTING;

EID: 70749146022     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2009.01237.x     Document Type: Article

References (44)

1. Turner G, Webb T, Wake S. Prevalence of fragile X syndrome. Am J Med Genet 1996, 64:196-197.
2. Song FJ, Barton P, Sleigntholme V. Screening for fragile-X syndrome: a literature review and modelling study. Health Technol Assess 2003, 7(16).
3. Pieretti M, Zhang FP, Fu YH. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991, 66:817-822.
4. Coffee B, Zhang F, Warren ST. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 1999, 22:98-101.
5. Rousseau F, Heitz D, Tarleton J. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2253 cases. Am J Hum Genet 1994, 55:225-237.
6. Rousseau F, Rouillard P, Morel ML. Prevalence of carriers of premutation-size alleles of the FMR1 gene and implications for the population genetics of the Fragile-X syndrome. Am J Hum Genet 1995, 57:1006-1018.
7. Dombrowski C, Levesque S, Morel ML. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 2002, 11:371-378.
8. Berkenstadt M, Ries-Levavi L, Cuckle H. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests. Prenat Diagn 2007, 27:991-994.
9. Crawford DC, Meadows KL, Newman JL. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet 1999, 64:495-507.
10. Turner G, Robinson H, Wake S. Dizygous twinning and premature menopause in fragile X syndrome. Lancet 1994, 344:1500.
11. Partington MW, Moore DY, Turner GM. Confirmation of early menopause in fragile X carriers. Am J Med Genet 1996, 64:370-372.
12. Vianna-Morgante AM, Costa SS, Pares AS. FRAXA premutation associated with premature ovarian failure. Am J Med Genet 1996, 64:373-375.
13. Murray A, Macpherson JN, Pound MC. The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission. Hum Mol Genet 1997, 6:173-184.
14. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 1999, 83:322-325.
15. Hundscheid RD, Smits AP, Thomas CM. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure. Am J Med Genet 2003, 117:6-9.
16. Jacquemont S, Hagerman RJ, Leehey MA. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004, 291:460-469.
17. Nolin SL, Brown WT, Glicksman A. Expansion of the Fragile X CGG repeat in females with permutation or intermediate alleles. Am J Hum Genet 2003, 72:454-464.
18. Heitz D, Rousseau F, Devys D. Isolation of sequences that span the fragile X and identification of a Fragile- X-related CpG island. Science 1991, 251:1236-1239.
19. Youings SA, Murray A, Dennis N. FRAXA and FRAXE: the results of a five year survey. J Med Genet 2000, 37:415-421.
20. Snow K, Tester DJ, Kruckeberg KE. Sequence analysis of the fragile X trinucleotide repeat: implications for the origin of the fragile X mutation. Hum Mol Genet 1994, 3:1553-1560.
21. Nolin SL, Lewis FA, Ye LL. Familial transmission of the FMR1 CGG repeat. Am J Hum Genet 1996, 59:1252-1261.
22. Murray A, Youings S, Dennis N. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mother. Hum Mol Genet 1996, 6:727-735.
23. Et la Santé, ça va en 1992-1993. Rapport de l'enquête sociale et de santé 1992-1993 Santé-Québec, Montréal, QC, Ministère de la Santé et des Services Sociaux, gouvernement du Québec
24. Rousseau F, Réhel R, Rouillard P. High throughput and economical mutation detection and RFLP analysis using a mini-method for DNA preparation from whole blood and acrylamide gel electrophoresis. Hum Mut 1994, 4:51-54.
25. Oberlé I, Rousseau F, Heitz D. Instability of a 550-base pair DNA segment and abnormal methylation in Fragile X syndrome. Science 1991, 252:1097-1102.
26. Chiurazzi P, Pomponi MG, Sharrock A. DNA panel for interlaboratory standardization of haplotype studies on the fragile X syndrome and proposal for a new allele nomenclature. Am J Med Genet 1999, 83:347-349.
27. Zhou Y, Law HY, Boehm CD. Robust fragile X CGG$_n$ genotype classification using a methylation specific triple PCR assay. J Med Genet 2004, 41:e45.
28. Nolin SL, Houck GE, Gargano AD. FMR1 CGG-repeat instability in single sperm and lymphocytes of fragile-X premutation males. Am J Hum Genet 1999, 65(3):680-688.
29. Tzeng CC, Tsai LP, Hwu WL. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype. Am J Med Genet 2005, 133:37-43.
30. Toledano-Alhadef H, Basel-Vanagaite L, Magal N. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet 2001, 69:351-360.
31. Eichler EE, Holden JJ, Popovich BW. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Mamm Genome 1994, 5:584-587.
32. Macpherson JN, Curtis G, Crolla JA. Unusual CGGn expansion and recombination in a family with fragile X and DiGeorge syndrome. J Med Genet 1995, 32:236-239.
33. Falik-Zaccai T, Shachak E, Yalon M. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruption on a rare Mediterranean haplotype. Am J Med Genet 1997, 60:103-112.
34. Kovtun IV, McMurray CT. Trinucleotide expansion in haploid germ cells by gap repair. Nat Genet 2001, 27:407-411.
35. Zhong N, Yang W, Dobkin C. Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet 1995, 57:351-361.
36. Ennis S, Murray A, Brightwell G. Closely linked cis-acting modifier of expansion of the CGG repeat in high risk FMR1 haplotypes. Hum Mutat 2007, 28:1216-1224.
37. Pearson CE, Nichol-Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005, 6:729-742.
38. Pesso R, Berkenstadt M, Cuckle H. Screening for fragile X syndrome in women of reproductive age. Prenat Diagn 2000, 20:611-614.
39. Rifé M, Badenas C, Mallolas J. Incidence of fragile X in 5,000 consecutive newborn males. Genet Test 2003, 7:339-343.
40. Gagne G, Reinharz D, Laflamme N. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms. Clin Genet 2007, 71:46-58.
41. Girouard J, Giguère Y, Delage R, Rousseau F. Prevalence of HFE gene C282Y and H63D mutations in a french-canadian population of neonates and in referred patients. Hum Mol Genet 2002, 11:185-189.
42. Garenc C, Aubert S, Laroche J. Population prevalence of APOE, APOC3 and PPAR-alpha mutations associated to hypertriglyceridemia in French Canadians. J Hum Genet 2004, 49:691-700.
43. Levesque S, Moutquin JM, Lindsay C. Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension 2004, 43:71-78.
44. Giroux S, Dubé-Linteau A, Cardinal G. Assessment of the prevalence of the 985A > G MCAD mutation in the French-Canadian population using allele-specific PCR: development and validation of a method based on pooling of DNA samples. Clin Genet 2007, 71:569-575.